The new tests for autism are not yet reliable enough to be offered commercially. None of the tests has gone through large ...
Opus Genetics, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback